News

LaunchPad Biomedical Innovation in Diabetes Applications

Link to Application

Launch Pad

Biomedical Innovation in Diabetes

Request For Applications

Application Due: July 29, 2016 at Noon

Senior Research Scientist Olga Cherepanova publishes Nature Medicine paper

Congratulations to Olga Cherepanova for her recently published Nature Medicine paper: "Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective"

Astrazeneca UVA Collaboration Video

We are working with the University of Virginia to develop innovative treatments for cardiovascular disease. The partnership supports preclinical to clinical research projects aimed at identifying disease mechanisms and biological targets with potential to become successful and commercially viable treatments in areas of high unmet medical need. Principal investigators from the university are matched with AstraZeneca researchers to accelerate the translation of research into new drugs, by tapping into the strengths of both partners.

Wagner Fellows named

Current CVTG trainees Tyler Basting (Guyenet lab) and Molly Kelly-Goss (Peirce-Cottler lab) and CVRC trainee Gabe Falcao Alencar (Owens lab) were named 2015 Wagner Fellows! Congratulations!

Grants and Awards

Tyler Basting, grad student in the Guyenet lab and currently on the CVTG won the 2015 Van Harreveld Memorial Award - Central Nervous System section of the American Physiological Society on how hypoxia silences the retrotrapezoid nucleus, a paper he recently published.